BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2021 9:46:23 AM | Browse: 604 | Download: 1338
 |
Received |
|
2021-03-17 16:15 |
|
Peer-Review Started |
|
2021-03-17 16:31 |
|
First Decision by Editorial Office Director |
|
2021-05-01 04:41 |
|
Return for Revision |
|
2021-05-01 04:41 |
|
Revised |
|
2021-05-06 17:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-20 08:18 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-20 11:10 |
|
Articles in Press |
|
2021-05-20 11:10 |
|
Edit the Manuscript by Language Editor |
|
2021-05-28 23:22 |
|
Typeset the Manuscript |
|
2021-06-22 03:44 |
|
Publish the Manuscript Online |
|
2021-06-25 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Opinion Review |
| Article Title |
Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Federico Piñero and Leonardo Gomes da Fonseca |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Federico Piñero, MD, MSc, Academic Research, Doctor, Doctor, Hepatology and Liver Unit, Hospital Universitario Austral, School of Medicine, Austral University, Av. Presidente Perón 1500, Pilar, Buenos Aires B1629HJ, Argentina. fpinerof@cas.austral.edu.ar |
| Key Words |
Eligibility; Systemic therapies; End-stage; Hepatocellular carcinoma |
| Core Tip |
The strict criteria used in clinical trials in advanced hepatocellular carcinoma have led to a scarcity of available data in a considerable proportion of patients in the real-world practice. The daily challenge of treating these underrepresented subgroups can be overcome by future clinical trials addressing special situations, collaborative studies and real-world data. |
| Publish Date |
2021-06-25 09:46 |
| Citation |
Piñero F, da Fonseca LG. Trial eligibility in advanced hepatocellular carcinoma: Does it support clinical practice in underrepresented subgroups? World J Gastroenterol 2021; 27(24): 3429-3439 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i24/3429.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i24.3429 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
